Author:
Wang Honglin,Lu Fangfang,Ni Xiuxian,Luo Rijing,Chen Linxiang,Yuan Jing,Zhang Zhen,Lv Qiuying
Abstract
Abstract
Background
The long-term sequelae of Coronavirus disease 2019 (COVID-19) in children are unclear. We investigated COVID-19 symptoms in school-aged children to determine their impact on patients and their families.
Methods
This cross-sectional study, conducted on February 25–28, 2023, selected a representative kindergarten and 9-year school from Shenzhen, China. There were randomly two classes each for the 12 grades from kindergarten to junior high school. The school-aged children were aged 3–16 years. Literate parents completed an online questionnaire related to their children’s COVID-19 symptoms since December 1, 2022. Descriptive statistics were computed as necessary. Univariate and multivariable linear regression analyses were performed, and variables with a p-value < 0.05 were considered to have a significant association with the subjective feeling scores for COVID-19 infection.
Results
We included 936 school-aged children, with a COVID-19 infection rate of 68.5%. The prevalence of LC 28 (illness with symptoms lasting for 28 days) was 3.4%. During acute infection, the median number of the 641 children’s symptoms was 3.0 (IQR: 1.0–5.0) and the median score of subjective feelings was 15.0 (IQR: 11.0–24.5). The top three symptoms were fever, cough/expectoration, and rhinobyon. Age of 13–16 years (adjusted beta: 3.60, 95% CI: 0.32–6.88) and comorbidities (adjusted beta: 3.47, 95% CI: 1.20–5.73) were independently associated with higher subjective feelings (p < 0.05). The top three characteristics associated with LC 28 were alopecia (33.3%, 5/15), cognitive dysfunction (29.2%, 7/24), and emotional problem (28.6%, 6/21).
Conclusions
Children with COVID-19 have a short duration of symptoms and milder symptoms, so they can self-medicate to minimize hospital crowding. Children with basic diseases require prompt attention. Although LC 28 is uncommon in children, mental and psychological problems after COVID-19 recovery should not be ignored.
Funder
The Key Project of Shenzhen Science and Technology Innovation Commission
Shenzhen Key Medical Discipline Construction Fund
Shenzhen San-Ming Project of Medicine in Shenzhen
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. World Health Organization. Listings of WHO’s response to COVID-19. Available at: Accessed on: 11 February 2022.
2. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available at: https://covid19.who.int/ Accessed on: March 13, 2023.
3. Asakawa T. Focusing on development of novel sampling approaches and alternative therapies for COVID-19: are they still useful in an era after the pandemic? Biosci Trends. 2022;16(6):386–8.
4. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–15.
5. COVID-19 rapid. Guideline: managing the long-term effects of COVID-19 (NG188. Evidence reviews 2 and 3: prevalence. London: National Institute for Health and Care Excellence (NICE); 2020.